1,2-Ethanediamine,N1-[(4-methoxyphenyl)methyl]-N2,N2-dimethyl-N1-2-pyrimidinyl-, hydrochloride(1:1) cas no:63-56-9
Synonyms: 1,2-Ethanediamine,N-[(4-methoxyphenyl)methyl]-N',N'-dimethyl-N-2-pyrimidinyl-, monohydrochloride(9CI); Pyrimidine, 2-[[2-(dimethylamino)ethyl](p-methoxybenzyl)amino]-,hydrochloride (7CI); Pyrimidine,2-[[2-(dimethylamino)ethyl](p-methoxybenzyl)amino]-, monohydrochloride (8CI);2-[(2-Dimethylaminoethyl)(p-methoxybenzyl)amino]pyrimidine hydrochloride;Anahist; N,N-Dimethyl-N'-(p-methoxybenzyl)-N'-(2-pyrimidyl)ethylenediaminehydrochloride; N-p-Methoxybenzyl-N',N'-dimethyl-N-2-pyrimidinylethylene diaminehydrochloride; NH 188; Neohetramine hydrochloride; Resistab; Super Anahist;Thonzylamine hydrochloride; Thonzylaminium chloride; Tonamil
Name1,2-Ethanediamine,N1-[(4-methoxyphenyl)methyl]-N2,N2-dimethyl-N1-2-pyrimidinyl-, hydrochloride(1:1)
CAS63-56-9
Synonyms1,2-Ethanediamine,N-[(4-methoxyphenyl)methyl]-N',N'-dimethyl-N-2-pyrimidinyl-, monohydrochloride(9CI); Pyrimidine, 2-[[2-(dimethylamino)ethyl](p-methoxybenzyl)amino]-,hydrochloride (7CI); Pyrimidine,2-[[2-(dimethylamino)ethyl](p-methoxybenzyl)amino]-, monohydrochloride (8CI);2-[(2-Dimethylaminoethyl)(p-methoxybenzyl)amino]pyrimidine hydrochloride;Anahist; N,N-Dimethyl-N'-(p-methoxybenzyl)-N'-(2-pyrimidyl)ethylenediaminehydrochloride; N-p-Methoxybenzyl-N',N'-dimethyl-N-2-pyrimidinylethylene diaminehydrochloride; NH 188; Neohetramine hydrochloride; Resistab; Super Anahist;Thonzylamine hydrochloride; Thonzylaminium chloride; Tonamil
EINECS(EC#)200-561-3
Molecular FormulaC16H22 N4 O . Cl H
Molecular Weight286.37208
Appearancewhite crystalline powder
Safety
Poison by ingestion, intravenous, and intraperitoneal routes. Used as an antihistamine. When heated to decomposition it emits very toxic fumes of HCl and NOx.
1. |
|
orl-mus LD50:245 mg/kg
|
|
NIIRDN “Drugs in Japan. Ethical Drugs, 6th Edition 1982“ Edited by Japan Pharmaceutical Information Center. 6 (1982),536. |
2. |
|
ipr-mus LD50:110 mg/kg
|
|
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. 123 (1960),419. |
3. |
|
orl-gpg LD50:493 mg/kg
|
|
NIIRDN “Drugs in Japan. Ethical Drugs, 6th Edition 1982“ Edited by Japan Pharmaceutical Information Center. 6 (1982),536. |
4. |
|
ivn-gpg LD50:38,200 µg/kg
|
|
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. 113 (1958),313. |